BRIEF-Aeglea Biotherapeutics Q1 net loss per share attributable to common stockholders $7.10 By: Reuters: Company News May 19, 2016 at 06:24 AM EDT * Has sufficient capital resources to fund anticipated operations through Q1 of 2018 Read More >> Related Stocks: Aeglea Biothera